SGK196 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.319600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.934800E-01
Normal-vs-Stage2
9.323600E-01
Normal-vs-Stage3
4.054200E-01
Normal-vs-Stage4
4.467000E-01
Stage1-vs-Stage2
1.308630E-01
Stage1-vs-Stage3
1.361810E-01
Stage1-vs-Stage4
6.518400E-01
Stage2-vs-Stage3
3.526200E-01
Stage2-vs-Stage4
3.564800E-01
Stage3-vs-Stage4
1.872240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.287600E-01
Normal-vs-AfricanAmerican
8.099000E-01
Normal-vs-Asian
4.119200E-01
Caucasian-vs-AfricanAmerican
5.869200E-01
Caucasian-vs-Asian
2.414600E-01
AfricanAmerican-vs-Asian
1.828420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.345000E-01
Normal-vs-Female
9.652200E-01
Male-vs-Female
3.571600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.068600E-01
Normal-vs-Age(41-60Yrs)
8.211000E-01
Normal-vs-Age(61-80Yrs)
8.248600E-01
Normal-vs-Age(81-100Yrs)
6.054800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.622400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.686200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.457600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.277840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.736000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.034000E-01
Normal-vs-Daily Drinker
4.707000E-01
Normal-vs-Weekly Drinker
8.961200E-01
Normal-vs-Occasional Drinker
9.708600E-01
Normal-vs-Social Drinker
8.332000E-01
Non Drinker-vs-Daily Drinker
5.064200E-01
Non Drinker-vs-Weekly Drinker
6.055800E-01
Non Drinker-vs-Occasional Drinker
2.590600E-01
Non Drinker-vs-Social Drinker
2.449200E-01
Daily Drinker-vs-Weekly Drinker
3.641600E-01
Daily Drinker-vs-Occasional Drinker
1.483560E-01
Daily Drinker-vs-Social Drinker
1.221020E-01
Weekly Drinker-vs-Occasional Drinker
7.541200E-01
Weekly Drinker-vs-Social Drinker
5.649400E-01
Occasional Drinker-vs-Social Drinker
6.997400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
2.877200E-01
Grade 1-vs-Grade 3
2.492200E-02
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
9.083600E-02
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.196600E-01
Normal-vs-NonDiabetic
6.677600E-01
Diabetic-vs-NonDiabetic
6.445200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.188600E-01
Normal-vs-NoPancreatitis
7.536200E-01
Pancreatitis-vs-NoPancreatitis
8.822600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.338600E-01
Normal-vs-N1
9.636400E-01
N0-vs-N1
8.497400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.078600E-01
Normal-vs-TP53-NonMutant
8.692400E-01
TP53-Mutant-vs-TP53-NonMutant
4.879800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
